Characterization of flagella produced by clinical strains of Stenotrophomonas maltophilia.
about
Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophiliaGenomic Potential of Stenotrophomonas maltophilia in Bioremediation with an Assessment of Its Multifaceted Role in Our EnvironmentStenotrophomonas maltophilia: an emerging global opportunistic pathogenIntestinal adherence associated with type IV pili of enterohemorrhagic Escherichia coli O157:H7Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients.Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence.The impact of spgM, rpfF, rmlA gene distribution on biofilm formation in Stenotrophomonas maltophiliaRisk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species.The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants.Flagellin and GroEL mediates in vitro binding of an atypical enteropathogenic Escherichia coli to cellular fibronectinHost protein binding and adhesive properties of H6 and H7 flagella of attaching and effacing Escherichia coli.Fourier transform infrared spectroscopy for rapid identification of nonfermenting gram-negative bacteria isolated from sputum samples from cystic fibrosis patientsStenotrophomonas, Mycobacterium, and Streptomyces in home dust and air: associations with moldiness and other home/family characteristics.Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.Synergistic role of curli and cellulose in cell adherence and biofilm formation of attaching and effacing Escherichia coli and identification of Fis as a negative regulator of curli.Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime.A Stenotrophomonas maltophilia multilocus sequence typing scheme for inferring population structure.Dissection of the role of pili and type 2 and 3 secretion systems in adherence and biofilm formation of an atypical enteropathogenic Escherichia coli strain.Differential biofilm formation and motility associated with lipopolysaccharide/exopolysaccharide-coupled biosynthetic genes in Stenotrophomonas maltophilia.Interaction of Escherichia coli O157:H7 with leafy green produce.Stenotrophomonas maltophilia fimbrin stimulates mouse bladder innate immune response.Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy.Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces.Stenotrophomonas maltophilia Serine Protease StmPr1 Induces Matrilysis, Anoikis, and Protease-Activated Receptor 2 Activation in Human Lung Epithelial Cells.Differential proteomic analysis of the response of Stenotrophomonas maltophilia to imipenem.Antifungal activity of Stenotrophomonas maltophilia in Stomoxys calcitrans larvae.Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.
P2860
Q24672751-AB822DCA-F1C0-4F12-A838-2511D590952FQ26742183-745EEEA5-8364-4198-A5A1-EE383E911AEDQ26995336-FEE7A81A-A9F7-473B-9FBE-73E1008149CEQ33377069-02E5D263-7876-4704-9818-5825EC71A1B8Q33550582-51318C35-9B13-4822-8285-BE3A1F0ED25EQ33950924-0E3DA547-E66E-4FA8-9786-77AE92FF4967Q34294110-2CE35B58-7CAE-4C75-88B9-F7285F599023Q34466373-43BE5A45-658C-4DF7-BAC9-31E31BC22ABAQ34770892-665E2521-059A-41E4-AC65-F34626858887Q35872237-5BF1CB69-276A-4749-884C-6950A093794CQ36314226-D5DCC48A-2EC1-4C93-B358-F62EE67C4D75Q36845344-C08F2EE4-A14B-46EE-A3D4-63CD41416184Q36920498-6E104D1E-01D3-4398-B590-F7CEF84D9CD3Q37866819-1597D6D1-D5D3-42EA-ACE0-C3FDDE5F406BQ39888521-C65416E8-B59F-4F0D-8101-9522655CE608Q40410432-211BF028-7BC7-4030-B8D8-D6E8F78DB7A2Q42215131-17108F08-280F-47EB-8C86-3948DAE4C68FQ42929874-2A0FDA3D-D7B9-4DE6-ABE8-A21060111DC9Q42941560-37E6D085-715D-4503-80F0-85EFA8C10BABQ43409125-24049FC6-35DA-46F5-935C-980CA8DAFCBFQ44954268-F2905FA8-0B0F-4287-B633-6223D53E9E7BQ47126542-FC66A8E6-5702-4FCB-9945-8F662086B6BDQ47682239-8DC34766-56BF-4E4C-B3A3-37B58F719D4FQ47820779-B85AD30C-7E6A-4285-82E0-029290C8DAFEQ49161535-673085D3-D90D-44D5-9E9D-A88C5E76076BQ52776419-50D3874C-88BA-4537-97E1-7450448EFA2DQ53297625-D8B71D42-B888-4359-ACC8-60A3BBAAEED1
P2860
Characterization of flagella produced by clinical strains of Stenotrophomonas maltophilia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of flagella p ...... Stenotrophomonas maltophilia.
@en
Characterization of flagella p ...... Stenotrophomonas maltophilia.
@nl
type
label
Characterization of flagella p ...... Stenotrophomonas maltophilia.
@en
Characterization of flagella p ...... Stenotrophomonas maltophilia.
@nl
prefLabel
Characterization of flagella p ...... Stenotrophomonas maltophilia.
@en
Characterization of flagella p ...... Stenotrophomonas maltophilia.
@nl
P2093
P2860
P356
P1476
Characterization of flagella p ...... Stenotrophomonas maltophilia.
@en
P2093
Ana C G S Azzuz
Doroti de Oliveira-Garcia
Jorge A Girón
Marina B Martinez
Monique Dall'Agnol
Mónica Rosales
P2860
P304
P356
10.3201/EID0809.010535
P577
2002-09-01T00:00:00Z